Effect of Atlas Cedarwood Essential Oil Aromatherapy on Sleep Quality Among Patients With Coronary Heart Disease
キーワード
概要
説明
The primary aim is testing the effect of Atlas cedar wood essential oil aromatherapy on sleep quality of patients after CHD.
The secondary aim is estimating the prevalence of sleep-wake disturbances (difficulty falling asleep, staying asleep, inadequate sleep duration, dissatisfaction with a sleep and excessive daytime sleepiness) among recruited CHD patients.
- data were collected by two phase:
- phase one: sleep quality of recruited CHD patients, who were admitted for undergoing coronary angiography electively, were assessed using Pittsburg Sleep Quality Index (PSQI). CHD participants who were reported poor sleep quality (=>5) in PSQI score will randomly allocated by toss either to intervention or control group.
- Phase two:
1. Intervention group received an atlas cedar wood aromatherapy for five consecutive nights.
2. Control group received no intervention.
3. Sleep quality of both group participants re-assessed at second day and six day of recruitment, respectively, using PSQI.
日付
| 最終確認済み: | 02/28/2019 |
| 最初に提出された: | 01/09/2019 |
| 提出された推定登録数: | 01/31/2019 |
| 最初の投稿: | 02/04/2019 |
| 最終更新が送信されました: | 03/26/2019 |
| 最終更新日: | 03/28/2019 |
| 実際の研究開始日: | 07/29/2018 |
| 一次完了予定日: | 11/04/2018 |
| 研究完了予定日: | 11/04/2018 |
状態または病気
介入/治療
Other: intervention group
段階
アームグループ
| 腕 | 介入/治療 |
|---|---|
| Experimental: intervention group product name: organic Atlas cedar wood essential oil (Cedrus Atlantica): the intervention group smell 2 drops of organic Atlas cedar wood essential oil (applied on cotton ball) for a period of five consecutive nights (at least 8 hours each night). | Other: intervention group At first day of admission, Intervention group received an intervention kit consist of 5 small glass essential oil bottles. Each essential oil bottle contains a small cotton ball saturated with two drops of Organic Atlas cedar wood essential oil (Cedrus Atantica). Participants were asked to open the bottle, inhale the smell directly and put it opened at 20 cm beside bed during night. |
| No Intervention: control group participants of this group received no intervention. |
適格基準
| 研究の対象となる年齢 | 20 Years に 20 Years |
| 研究に適格な性別 | All |
| 健康なボランティアを受け入れる | はい |
| 基準 | Inclusion Criteria: 1. stable CHD patients with history of myocardial infarction, stable angina, unstable angina or acute coronary syndrome who were admitted for elective coronary angiograph (cardiac catheterization) during the study period. 2. age of participants must be between 20-64 years old. 3. participants must have an ability to understand and communicate with the researchers. Exclusion Criteria: included CHD patient were excluded if they: 1. pregnant women or who has a plan for pregnancy as well as any patients who their care giver is pregnant 2. have a recent cardiac attack within 24-48 hours or had a history or risk of heart failure or cardiogenic shock were excluded. 3. have problems in smell sensations , history of breathing difficulties and disorders such as asthma, sleep apnea or allergies to plants and flowers parts were excluded, too. 4. have history of psychological disorders (i.e., depression) or psychiatric disorders (i.e., schizophrenia) were excluded 5. using prescribed sedatives drugs or other complementary therapy likes herbal remediates or even aromatherapy in recent one week were excluded 6. shift workers. |
結果
主な結果の測定
1. Demographic and Situational Data Sheet [at the day of admission]
2. sleep quality score during past month before admission using Arabic version of PITTSBURGH SLEEP QUALITY INDEX (PSQI) [during past month before admission]
3. sleep quality score during past day of hospitalization (before undergoing cardiac catheterization) using Arabic version of PITTSBURGH SLEEP QUALITY INDEX (PSQI) [one day during hospitalization]
4. sleep quality score during past five days (after undergoing cardiac catheterization) using Arabic version of PITTSBURGH SLEEP QUALITY INDEX [five days after admission]
